Dergiler / Turkish Journal of Medical Sciences / 2014 / Cilt: 44 - Sayı: 6

Detection of the frequency of PER-1 type extended-spectrum β-lactamase producing Acinetobacter baumannii clinical isolates in Turkey: a multicenter study

Sayfa
1041–1046
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

However, the increased carbapenem resistance, together with multidrug resistance, has created a worrisome situation regarding this pathogen.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: β-Lactamases are an important resistance mechanism in Acinetobacter baumannii.
📊
Temel Bulgular & Veri:Pseudomonas extended-resistance (PER-1) type β-lactamase producing strains have been reported from various geographic locations; however, PER-1 type β-lactamases from Turkish hospitals have not been investigated extensively.
💡
Sonuç & Katkı:However, the increased carbapenem resistance, together with multidrug resistance, has created a worrisome situation regarding this pathogen.
🔬Tür:Araştırma Makalesi
📍Kapsam:2008 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: β-Lactamases are an important resistance mechanism in Acinetobacter baumannii. Pseudomonas extended-resistance (PER-1) type β-lactamase producing strains have been reported from various geographic locations; however, PER-1 type β-lactamases from Turkish hospitals have not been investigated extensively. The aim of this study was to determine the prevalence of PER-1 type β-lactamases in A. baumannii isolates in various regions of Turkey. Materials and methods: A total of 763 clinical A. baumannii isolates were collected from 9 university hospitals and 2 state hospitals between 2008 and 2011. Molecular amplification of the OXA-51 gene from the A. baumannii genome was performed in order to verify identification of the species. Real-time polymerase chain reaction was used to detect blaPER-1 genes. Results: PER-1 was detected in 24.6% of the isolates. The annual frequencies of the PER-1 enzyme were detected as 52.2%, 35.9%, and 8.3% in 2008, 2009, and 2010, respectively. PER-1 prevalence decreased gradually over time. The differences observed in PER-1 prevalence among the regions of Turkey were statistically significant (chi-square test; P < 0.001). Conclusion: These data demonstrate that the frequency of detection of PER-1 type β-lactamases in A. baumannii species has decreased in Turkey. However, the increased carbapenem resistance, together with multidrug resistance, has created a worrisome situation regarding this pathogen.

🔖

Bu Makaleye Atıf Yap

ÖZDEMİR, M., ÇİFTCİ, İ. H., ÖKSÜZ, L., KOÇOĞLU, M. E., BERKTAŞ, M., SEYREK, A., SESLİ, E. Ç., AYYILDIZ, A., YAĞCI, S., KURTOĞLU, M. G., GÜL, M., AŞIK, G. (2022). Detection of the frequency of PER-1 type extended-spectrum β-lactamase producing Acinetobacter baumannii clinical isolates in Turkey: a multicenter study. Turkish Journal of Medical Sciences, Cilt: 44 - Sayı: 6, 1041–1046. https://ajindex.com/articles/610982

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Bergogne-Berezin E. Resistance of Acinetobacter spp. to antimicrobials: overview of clinical resistance patterns and therapeutic problems. In: Bergogne-Berezin E, Joly-Guillou ML, Towner KJ, editors. Acinetobacter: Microbiology, Epidemiology, Infections, Management. Boca Raton, FL, USA: CRC Press; 1996. pp. 133–183
  2. Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med 2008; 358: 1271–1281
  3. Towner KJ. Molecular basis of antibiotic resistance in Acinetobacter spp. In: Gerisher U, editor. Acinetobacter Molecular Biology. Norfolk, UK: Caister Academic Press; 2008. pp. 322–343
  4. Brown S, Young HK, Amyes SGB. Characterisation of OXA-51, a novel class D cephalosporinase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin Microbiol Infect 2005; 11: 15–23
  5. Nordman P, Ronco E, Naas T, Duport C, Michel Briand Y, Labia R. Characterization of a novel extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother 1993; 37: 962–969
  6. Vahaboglu H, Ozturk R, Aygun G, Coskunkan F, Yaman A, Kaygusuz A, Leblebicioglu H, Balik I, Aydin K, Oktun M. Widespread of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob Agents Chemother 1997; 41: 2265–2269
  7. Kolayli F, Gacar G, Karadenizli A, Sanic A, Vahaboglu H. PER- 1 is still widespread in Turkish hospitals among Pseudomonas aeruginosa and Acinetobacter spp. FEMS Microbiol Lett 2005; 249: 241–245
  8. Erac B, Gulay Z. Molecular epidemiology of PER-1 extended spectrum β-lactamase among gram-negative bacteria isolated at a tertiary care hospital. Folia Microbiol 2007; 52: 535–541
  9. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, 17th Informational Supplement. Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2007
  10. Bogner PN, Killeen AA. Extraction of nucleic acids. In: Coleman WB, Tsongalis GJ, editors. Molecular Diagnostics: For the Clinical Laboratorian. New York, NY, USA: Humana Press; 2007. pp. 25–30
  11. Adams-Haduch JM, Paterson DL, Sidjabat HE, Pasculle AW, Potoski BA, Muto CA, Harrison LH, Doi Y. Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania. Antimicrob Agents Chemother 2008; 52: 3837–3843
  12. Turner PJ, Greenhalgh JM; MYSTIC Study Group (Europe). The activity